Concepedia

Maternal Toxicity With Continuous Nevirapine in Pregnancy

Jane Hitti, Lisa M. Frenkel, Alice Stek, Sharon Nachman, David A. Baker, Adolfo González-García, Arthur J. Provisor, Edwin Thorpe, Mary E. Paul, Marc Foca,

JAIDS Journal of Acquired Immune Deficiency Syndromes · 2004 · 144 citations · 6 references

DOI

Abstract

Continuous nevirapine may be associated with increased toxicity among HIV-1-infected pregnant women with CD4 cell counts greater than 250 cells/microL, as has been observed in non-pregnant women.

References

6

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

Laura Guay, Philippa Musoke, Thomas R. Fleming et al. · The Lancet · 1999 · 1.6K citations

, , +6

Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV Transmission<SUBTITLE>A Randomized Trial</SUBTITLE>

Alejandro Dorenbaum · JAMA · 2002 · 370 citations

A Multicenter Randomized Controlled Trial of Nevirapine Versus a Combination of Zidovudine and Lamivudine to Reduce Intrapartum and Early Postpartum Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1

Dhayendre Moodley, Jagidesa Moodley, Hoosen Coovadia et al. · The Journal of Infectious Diseases · 2003 · 344 citations · Full text

A Comprehensive Hepatic Safety Analysis of Nevirapine in Different Populations of HIV Infected Patients*

Jerry O. Stern, Patrick Robinson, James E. Love et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2003 · 237 citations

, , +20

Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus*1

Eric Knudtson · Obstetrics and Gynecology · 2003 · 40 citations